ARCHIVES

Drug Company Cries Foul Over Clams Of Taxotere’s Superiority To Taxol

This article is from The Cancer Letter archive.

Vol. 19 No. 24 | June 11, 1993

Download PDF Visit The Full Archive

Related Articles

Risk-Benefit Analysis Advised Prior To Hormone Therapy

August 27, 2010

NCI-Approved Clinical Trials Listed For Month Of March

April 27, 2001

NCI exceeds employment ceilings, must cut personnel in FY 2004, NIH says. Further cuts expected in extramural grant support staff.

January 30, 2004

Wyngaarden Law With Appointment Report; DeVita Tells Congress “We’re Addressing The Issue Internally”

March 20, 1987

Letter to the Editor

March 21, 2003

What Peace Divided? Mideast Crisis Means NCI Will Be Lucky To Keep House Increase

August 31, 1990